The company is making a shift to focus on only the highest-value GenAI use cases and shut down pilots that were redundant or ...

Johnson & Johnson is increasing its dividend for the 63rd consecutive year. This further cements the healthcare giant's ...

Johnson & Johnson on Tuesday reported better-than-expected first-quarter results and lifted its sales forecast for the full ...

Health care giant Johnson & Johnson expects about $400 million in tariff-related costs this year. The costs will be felt ...

In this article, we are going to take a look at where Johnson & Johnson (NYSE:JNJ) stands against other best dividend monarchs. Dividend-focused investors are generally well-acquainted with terms ...

Joaquin Duato; Chairman of the Board, Chief Executive Officer; Johnson & Johnson John Reed; Executive Vice President - Innovative Medicine, Research and Development; Johnson & Johnson Joseph Wolk ...

Johnson & Johnson (JNJ.N), opens new tab Chief Executive Joaquin Duato said on Tuesday that tariffs on pharmaceuticals can create supply chain disruptions and that favorable tax policies would be ...

At Johnson & Johnson, we believe health is everything. Our strength in healthcare innovation empowers us to build a world where complex diseases are prevented, treated, and cured, where treatments ...